Cart
sales@molnova.com
Muscimol HBr
CAS No. 18174-72-6
Muscimol HBr( Muscimol Hydrobromide | Agarin hydrobromide | Agarin HBr )
Catalog No. M27306 CAS No. 18174-72-6
Muscimol HBr is an agonist of GABAA receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 216 | In Stock |
|
| 2MG | 173 | In Stock |
|
| 5MG | 253 | In Stock |
|
| 10MG | 407 | In Stock |
|
| 25MG | 656 | In Stock |
|
| 50MG | 927 | In Stock |
|
| 100MG | 1237 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2502 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMuscimol HBr
-
NoteResearch use only, not for human use.
-
Brief DescriptionMuscimol HBr is an agonist of GABAA receptor.
-
DescriptionMuscimol HBr is an agonist of GABAA receptor.
-
In Vitro——
-
In Vivo——
-
SynonymsMuscimol Hydrobromide | Agarin hydrobromide | Agarin HBr
-
PathwayOthers
-
TargetOther Targets
-
Recptorprotein tyrosine phosphatase(PTP)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18174-72-6
-
Formula Weight195.016
-
Molecular FormulaC4H7BrN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESBr.NCc1cc(=O)[nH]o1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stanford SM1, et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol. 2017 Jun;13(6):624-632.
molnova catalog
related products
-
Polysorbate 20
Polysorbate 20 (Tween-20) ,sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives, is used in the formulation of biotherapeutic products for both preventing surface adsorption and as a stabilizer against protein aggregation.
-
Acetylhydroquinone
1. 2, 5-Dihydroxyacetophenone possess anti-anxiety, and neuroprotective qualities. 2. 2, 5-Dihydroxyacetophenone treatment can induce a sustained activation of JNK, ERK1/2, and p38 MAPKs.
-
S107
S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
